Skip to main content

September 2022 - Welcome to the NCI Bottom Line Blog

    • Cancer Moonshot Scholars: Tapping a Deep Pool of Talent
      , by NCI Acting Director Dr. Douglas R. Lowy and CRCHD Director Dr. Sanya A. Springfield

      While NCI has long been committed to workforce diversity, there remains a disproportionate gap in R01 grants received by individuals from underrepresented groups. The new Cancer Moonshot Scholars program aims to help close this gap. In this edition of the NCI Bottom Line blog, Drs. Lowy and Springfield provide details on this innovative program and encourage eligible Early-Stage Investigators to apply to become a scholar.

      Continue Reading >

    • Raising the R01 Payline and Funding Other NCI Priorities
      , by NCI Acting Director Dr. Douglas R. Lowy and NCI Associate Director for Finance and Legislation Patrick McGarey

      In this edition of the NCI Bottom Line, NCI Acting Director Dr. Lowy and NCI Associate Director for Finance and Legislation Patrick McGarey explain why raising the R01 payline to the 15th percentile by fiscal year 2025 and supporting more R01 grant awards is a top priority for NCI. They also explain why allocating funds for this priority must be balanced with maintaining other critical NCI programs extramural scientists rely on to support their research.

      Continue Reading >